Literature DB >> 19161254

Stereocontrolled synthesis of complicated oxacyclic compounds via platinum-catalyzed [4 + 2]-cycloadditions and annulations of enynals with allylic alcohols.

Yu-Chia Hsu1, Chun-Ming Ting, Rai-Shung Liu.   

Abstract

We report stereoselective synthesis of tricyclic ketals through Pt(II)-catalyzed [4 + 2]-cycloaddition of benzopyrilium/1-en-3-ol functionalities. For nonaromatic enynals, we obtained distinct tricyclic oxacyclic ketones due to occurrence of a new annulation reaction. This work reports the first example that [4 + 2]-cycloadducts are successfully intercepted from such functionalities in diversified approaches. The value of such cycloadditions and annulations are shown by their high diastereoselectivities and chemoselectivities.

Entities:  

Year:  2009        PMID: 19161254     DOI: 10.1021/ja809560c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Ruthenium(0)-Catalyzed [4+2] Cycloaddition of Acetylenic Aldehydes with α-Ketols: Convergent Construction of Angucycline Ring Systems.

Authors:  Aakarsh Saxena; Felix Perez; Michael J Krische
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-09       Impact factor: 15.336

2.  Rh(i)-catalyzed stereoselective desymmetrization of prochiral cyclohexadienones via highly exo-selective Huisgen-type [3 + 2] cycloaddition.

Authors:  Krishna Kumar Gollapelli; Vaibhav B Patil; Allam Vinaykumar; Rambabu Chegondi
Journal:  Chem Sci       Date:  2020-11-27       Impact factor: 9.825

3.  Gold-catalyzed cyclization of allenyl acetal derivatives.

Authors:  Dhananjayan Vasu; Samir Kundlik Pawar; Rai-Shung Liu
Journal:  Beilstein J Org Chem       Date:  2013-08-27       Impact factor: 2.883

4.  Development of a Cross-Conjugated Vinylogous [4+2] Anionic Annulation and Application to the Total Synthesis of Natural Antibiotic (±)-ABX.

Authors:  Jing-Kai Huang; Kak-Shan Shia
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-25       Impact factor: 15.336

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.